Published date: 17 January 2023

Last edited date: 25 January 2023

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 21 February 2023, 1pm

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£31,584,025

Procurement reference

CF-1275100D0O000000rwimUAA

Published date

17 January 2023

Closing date

21 February 2023

Closing time

1pm

Contract start date

1 May 2023

Contract end date

1 January 2025

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection

Offer reference number: CM/PHG/22/5694
FIND A TENDER (FTS) Reference number

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

CM/PHG/22/5694/00 - Dasatinib
CESW 01/05/2023 - 30/04/2024 - (12 Months)
LSNE 01/05/2023 - 30/04/2024 - (12 Months)
NWLN 01/05/2023 - 30/04/2024 - (12 Months)

CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE 01/05/2023 - 31/05/2024 (13 Months)
NWLN 01/05/2023 - 31/01/2025 (21 months)

More information

Previous notice about this procurement

NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

  • Opportunity
  • Published 17 January 2023

Attachments

About the buyer

Contact name

sharron giblin

Address

Rutland House
Runcorn
WA7 2ES
UK

Email

sharron.giblin@nhs.net